DOCSLIB.ORG

Artemis Health Tariff.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Artemis Health Tariff.Pdf Billing Sr No Procedure Type Codes Procedure Name Price 1 Ambulance Charges EMA001 Ambulance Base Charges(ACLS) 832 2 Ambulance Charges EMA002 Ambulance Rate(ACLS) 44 3 Ambulance Charges EMA003 Ambulance Waiting Time (after 1st hour) 1,556 4 Ambulance Charges EMA004 Doctors Charges Per hour after 2 hours 886 5 Ambulance Charges EMA005 Oxygen 303 6 Ambulance Charges EMA006 Monitor 303 7 Ambulance Charges EMA007 Ventilator 2,344 8 Ambulance Charges EMA008 Porta Vent (ER) 303 9 Ambulance Charges EMA010 TranscutaneousTemporaryCardiacPacing(Am) 1,426 10 Ambulance Charges EMA015 Splinting 1,556 11 Ambulance Charges EMA017 Foley Catheterization 638 12 Ambulance Charges EMA023 ASSISTED MANUAL VENTILATION(AMBULANCE) 918 13 Ambulance Charges EMA025 Consultant Charges Ambulance 1,556 14 Ambulance Charges EMA206 Ryles Tube Insertion 638 15 Ambulance Charges EMA021 Doctors charges (min 2 hrs) 1,394 16 Ambulance Charges EMA100 Ambulance Base Rate(BLS) 638 17 Ambulance Charges EMA101 Ambulance Rate(BLS) 33 18 Anesthesia ANZ112 Unstable patient management 6,264 19 Anesthesia ANZ113 ACT 141 20 Anesthesia ANZ114 FSBS 141 21 Anesthesia ANZ115 Epidural steroid injection 3,564 22 Anesthesia ANZ093 MD Anesthetist for Ambulance (4 hours) 3,564 23 Anesthesia ANZ094 MD Anesthetist for Ambulance (addl hour) 1,556 24 Anesthesia ANZ095 CODE BLUE 3,564 25 Anesthesia ANZ096 Stand by anaesthes for Diagnostics/other 994 26 Anesthesia ANZ098 GA for ECT 3,564 27 Anesthesia ANZ101 Anesthesia visit for emergency managemen 1,556 28 Anesthesia ANZ099 MAC (Sedation) for cath procedures 2,830 29 Anesthesia ANZ048 Sedation for Nacro Analysis 3,564 30 Anesthesia ANZ049 GA for Cath Lab Procedures 5,400 31 Anesthesia ANZ023 ABG sampling 562 32 Anesthesia ANZ024 I/V cannula on floors 918 33 Anesthesia ANZ025 PCEA (patient controlled epidural anaest 5,400 34 Anesthesia ANZ026 Single shot nerve block 2,333 35 Anesthesia ANZ028 BiPAP initiation 476 36 Anesthesia ANZ029 Daily follow up of BiPAP 476 37 Anesthesia ANZ033 Ryles tube insertion- Anesthesia 638 38 Anesthesia ANZ034 OT charges for C arm use < 30 min 2,560 39 Anesthesia ANZ035 OT charges for C arm use > 30 min 3,845 40 Anesthesia ANZ037 Arterial line placement 2,830 41 Anesthesia ANZ038 PA catheter placement 3,564 42 Anesthesia ANZ039 Patient controlled analgesia 3,564 43 Anesthesia ANZ041 MAC per hr >2 hr 2,333 44 Anesthesia ANZ042 MAC for Diagnostics 3,564 45 Anesthesia ANZ043 General anaesthesia for Diagnostic 5,400 46 Anesthesia ANZ046 MAC for cath lab procedures 5,400 47 Anesthesia ANZ047 Labour epidural for analgesia(CSE/EA) 11,675 48 Anesthesia ANZ052 Anesthesia Charges (Ambulance) 3,564 49 Anesthesia ANZ050 Caudal Injection (Single Shot) 5,400 50 Anesthesia ANZ051 Caudal Anesthesia (Continuous) 11,675 51 Anesthesia ANZ203 Sedation charges fo Endoscopy 216 52 Anesthesia ANZ002 Central Line/PIC line Insertion 3,564 53 Anesthesia ANZ004 Trans Esophageal Echocardiography 3,759 54 Anesthesia ANZ005 Epidural Catheter Insertion 6,264 55 Anesthesia ANZ009 Consultation / PAC 713 56 Anesthesia ANZ012 Intubation and Ventilator Mgmt 2,333 57 Anesthesia ANZ013 Continuous Plexus Block 4,558 58 Anesthesia ANZ016 Intercoastal Nerve Block 2,333 59 Anesthesia ANZ017 Anaesthesia Consultation 713 60 Anesthesia ANZ018 Bronchoscope assistance in anaesthesia 3,564 61 Anesthesia ANZ020 Sedation for dressing 918 62 Anesthesia ANZ054 CT Guided Procedure (GA) 3,564 63 Anesthesia ANZ191 Epidural blood patch 3,564 64 Anesthesia ANZ192 Intra Muscular Stimulation 1,275 65 Anesthesia ANZ092 Epidural blood patch 3,208 66 Anesthesia ANZ110 Femoral vein Acess 1,556 67 Anesthesia ANZ111 Consultation pain management 713 68 Angiography CAG004 Coronary Angiography Investiga 1,318 69 Antenatal Programme GYA1 Antenatal Prg Trim 1 8,414 70 Artficial Limb MSC111 Myoelectric hand with mechanical elbow 534,600 71 Artficial Limb MSC112 Myoelectric hand with electronic elbow 1,188,000 72 Artficial Limb MSC113 Bionic hand 1,425,600 73 Artficial Limb MSC114 Shoulder disarticulation-1 356,400 74 Artficial Limb MSC115 Shoulder disarticulation-2 415,800 75 Artficial Limb MSC116 Shoulder disarticulation-3 457,380 76 Artficial Limb MSC117 Shoulder disarticulation-4 594,000 77 Artficial Limb MSC268 Forearm with gauntlet 1,664 78 Artficial Limb MSC269 Full arm gauntlet with shoulder straps 2,376 79 Artficial Limb MSC207 Tennis Elbow support 443 80 Artficial Limb MSC208 Sling & Swathe 951 81 Artficial Limb MSC209 Clavicle support 832 82 Artficial Limb MSC210 Elbow wrap 357 83 Artficial Limb MSC211 Wrist & thumb support 638 84 Artficial Limb MSC212 shoulder immobilizer 1,145 85 Artficial Limb MSC213 Wrist wrap 562 86 Artficial Limb MSC214 Finger frog splint 173 87 Artficial Limb MSC215 Dynamic Radial palsy splint 2,970 88 Artficial Limb MSC216 Dynamic wrist hand orthosis with finger extension assist 4,752 89 Artficial Limb MSC217 CTEV Splint 1,188 90 Artficial Limb MSC218 Solid ankle AFO 2,376 91 Artficial Limb MSC219 CP AFO 5,940 92 Artficial Limb MSC220 Hip abduction Brace 10,692 93 Artficial Limb MSC221 Pelvic harness 14,256 94 Artficial Limb MSC242 L S Belt custom 4,158 95 Artficial Limb MSC243 Boston Brace 14,256 96 Artficial Limb MSC244 Milwaukee brace 19,008 97 Artficial Limb MSC245 A S H Brace-1 1,188 98 Artficial Limb MSC246 A S H Brace-2 3,564 99 Artficial Limb MSC247 Jewitt-1 4,158 100 Artficial Limb MSC248 Jewitt-2 11,880 101 Artficial Limb MSC249 Jewitt-3 21,384 102 Artficial Limb MSC250 Below knee compression garment-1 2,139 103 Artficial Limb MSC251 Below knee compression garment-2 1,426 104 Artficial Limb MSC253 Below knee compression garment-3 2,376 105 Artficial Limb MSC254 Thigh length compression garment-1 2,970 106 Artficial Limb MSC255 Thigh length compression garment-2 4,158 107 Artficial Limb MSC256 Full length compression garment 4,752 108 Artficial Limb MSC257 Waist height both legs 7,247 109 Artficial Limb MSC258 Waist height one full leg one above knee 6,772 110 Artficial Limb MSC259 Waist height one full leg open pubis 4,990 111 Artficial Limb MSC260 Waist height both above knee 4,634 112 Artficial Limb MSC261 High waist panty with calf 6,534 113 Artficial Limb MSC262 High waist panty above knee 5,703 114 Artficial Limb MSC263 Panty with calf 5,465 115 Artficial Limb MSC264 Panty above knee 4,634 116 Artficial Limb MSC265 Forearm 1,188 117 Artficial Limb MSC266 Full arm 1,782 118 Artficial Limb MSC267 Full arm with shoulder staps 2,139 119 Artficial Limb MSC501 ABOVE KNEE PROSTHESIS PNEUMATIC JOINT 392,040 120 Artficial Limb MSC101 Silicon (cosmetic)finger(partial amputation) 19,008 121 Artficial Limb MSC102 Full finger 21,384 122 Artficial Limb MSC103 Thumb 21,384 123 Artficial Limb MSC104 Partial hand 95,040 124 Artficial Limb MSC105 Cosmetic hand-Below elbow-1 59,400 125 Artficial Limb MSC106 Cosmetic hand-Below elbow-2 106,920 126 Artficial Limb MSC107 Mechanical below elbow-1 95,040 127 Artficial Limb MSC108 Mechanical below elbow-2 118,800 128 Artficial Limb MSC109 Myoelectric hand Below elbow-1 285,120 129 Artficial Limb MSC110 Myoelectric hand Below elbow-2 415,800 130 Artficial Limb MSC122 Below knee-3 47,520 131 Artficial Limb MSC040 Abdominal Binder small width 1,782 132 Artficial Limb MSC159 Ankle wrap-1 713 133 Artficial Limb MSC160 Ankle wrap-2 1,782 134 Artficial Limb MSC161 Ankle wrap-3 5,940 135 Artficial Limb MSC162 Ankle stirrup-1 1,188 136 Artficial Limb MSC163 Ankle stirrup-2 2,970 137 Artficial Limb MSC164 Ankle stirrup-3 8,910 138 Artficial Limb MSC165 AFO-1 594 139 Artficial Limb MSC166 AFO-2 2,376 140 Artficial Limb MSC167 AFO-3 4,158 141 Artficial Limb MSC168 Pneumatic walker-1 8,316 142 Artficial Limb MSC169 Pneumatic walker-2 11,880 143 Artficial Limb MSC170 Pneumatic walker-3 17,820 144 Artficial Limb MSC171 Web Spacer -1 594 145 Artficial Limb MSC172 Web Spacer -2 832 146 Artficial Limb MSC173 Knee Cap-1 713 147 Artficial Limb MSC174 Knee Cap-2 1,782 148 Artficial Limb MSC175 Knee Cap-3 5,346 149 Artficial Limb MSC176 Knee cap with hinges-1 951 150 Artficial Limb MSC177 Knee cap with hinges-2 1,782 151 Artficial Limb MSC178 Knee cap with hinges-3 4,158 152 Artficial Limb MSC179 OA knee Brace-1 11,880 153 Artficial Limb MSC180 OA knee Brace-2 23,760 154 Artficial Limb MSC181 OA knee Brace-3 47,520 155 Artficial Limb MSC270 Vest without sleeves 4,515 156 Artficial Limb MSC271 Vest with full sleeves 6,653 157 Artficial Limb MSC272 Vest with half sleeves 5,703 158 Artficial Limb MSC273 Glove 1,188 159 Artficial Limb MSC274 Facemask 1,426 160 Artficial Limb MSC275 Side open binder extra wide 2,614 161 Artficial Limb MSC276 High waisted shorts type abdominal binder 4,752 162 Artficial Limb MSC277 Below knee stump support-1 2,376 163 Artficial Limb MSC278 Below knee stump support-2 3,564 164 Artficial Limb MSC279 Below knee stump support-3 5,940 165 Artficial Limb MSC280 Above knee stump support-1 4,158 166 Artficial Limb MSC281 Above knee stump support-2 6,534 167 Artficial Limb MSC282 Above knee stump support-3 8,910 168 Artficial Limb MSC283 extra straps 292 169 Artficial Limb MSC284 scrotal support-1 767 170 Artficial Limb MSC285 scrotal support-2 1,188 171 Artficial Limb MSC182 OA knee Brace-4 77,220 172 Artficial Limb MSC183 Elbow crutches-1 1,188 173 Artficial Limb MSC184 Elbow crutches-2 1,782 174 Artficial Limb MSC185 Cast shoe-1 951 175 Artficial Limb MSC186 Cast shoe-2 1,782 176 Artficial Limb MSC187 Cast shoe-3 2,376 177 Artficial Limb MSC188 Finger Splint-1 238 178 Artficial Limb MSC189 Finger Splint-2 713 179 Artficial Limb MSC190 Finger Splint-3 1,426 180 Artficial Limb MSC191 Knuckle bender
Load more

Recommended publications
  • Index to the NLM Classification 2011
    National Library of Medicine Classification 2011 Index Disease see Tyrosinemias 1-8 5,12-diHETE see Leukotriene B4 1,2-Benzopyrones see Coumarins 5,12-HETE see Leukotriene B4 1,2-Dibromoethane see Ethylene Dibromide 5-HT see Serotonin 1,8-Dihydroxy-9-anthrone see Anthralin 5-HT Antagonists see Serotonin Antagonists 1-Oxacephalosporin see Moxalactam 5-Hydroxytryptamine see Serotonin 1-Propanol 5-Hydroxytryptamine Antagonists see Serotonin Organic chemistry QD 305.A4 Antagonists Pharmacology QV 82 6-Mercaptopurine QV 269 1-Sar-8-Ala Angiotensin II see Saralasin 7S RNA see RNA, Small Nuclear 1-Sarcosine-8-Alanine Angiotensin II see Saralasin 8-Hydroxyquinoline see Oxyquinoline 13-cis-Retinoic Acid see Isotretinoin 8-Methoxypsoralen see Methoxsalen 15th Century History see History, 15th Century 8-Quinolinol see Oxyquinoline 16th Century History see History, 16th Century 17 beta-Estradiol see Estradiol 17-Ketosteroids WK 755 A 17-Oxosteroids see 17-Ketosteroids A Fibers see Nerve Fibers, Myelinated 17th Century History see History, 17th Century Aardvarks see Xenarthra 18th Century History see History, 18th Century Abate see Temefos 19th Century History see History, 19th Century Abattoirs WA 707 2',3'-Cyclic-Nucleotide Phosphodiesterases QU 136 Abbreviations 2,4-D see 2,4-Dichlorophenoxyacetic Acid Chemistry QD 7 2,4-Dichlorophenoxyacetic Acid General P 365-365.5 Organic chemistry QD 341.A2 Library symbols (U.S.) Z 881 2',5'-Oligoadenylate Polymerase see Medical W 13 2',5'-Oligoadenylate Synthetase By specialties (Form number 13 in any NLM
    [Show full text]
  • Abstract Book
    AEPROMO, 2012 Revista Española de Ozonoterapia Vol.2 No. 2. Supplement 1, 2012, ISSN 2174‐3215 III International Congress of AEPROMO "The ozonetherapy in the medical agenda" Spanish Association of Medical Professionals in Ozone Therapy III International Congress of AEPROMO 7th -9th June, 2012. Complutense University of Madrid, Spain. Abstract Book Abstract Book 7th - 9th June, 2012. Complutense University of Madrid, Spain. Organizer: Spanish Association of Medical Professionals in Ozone Therapy (AEPROMO) Page 1 of 117 AEPROMO, 2012 Revista Española de Ozonoterapia Vol.2 No. 2. Supplement 1, 2012, ISSN 2174‐3215 III International Congress of AEPROMO "The ozonetherapy in the medical agenda" Spanish Association of Medical Professionals in Ozone Therapy Index Scientific Committee ......................................................................................................................................................................... 4 Organizing committee....................................................................................................................................................................... 4 Sponsors........................................................................................................................................................................................... 5 Preface.............................................................................................................................................................................................. 8 Conference Agenda
    [Show full text]
  • Abstract Book 10Th -12Th November, 2011 Hotel Great Parnasuss, Cancun, Mexico
    AMOZON, 2011 Revista Española de Ozonoterapia Vol.2 Supplement 1 2012, ISSN 2174-3215 II International Medical Ozone Federation Congress. IMEOF III Mexican Ozonetherapy Association Congress. AMOZON "For the Integration of Ozonetherapy into the Conventional Medicine” II International Medical Ozone Federation Congress. IMEOF III Mexican Ozonetherapy Association Congress. AMOZON "For the Integration of Ozonetherapy into the Conventional Medicine” AAbbssttrraacctt BBooookk Abstract Book 10th -12th November, 2011 Hotel Great Parnasuss, Cancun, Mexico Organizer: Mexican Ozonetherapy Association (AMOZON) Page 1 of 121 AMOZON, 2011 Revista Española de Ozonoterapia Vol.2 Supplement 1 2012, ISSN 2174-3215 II International Medical Ozone Federation Congress. IMEOF III Mexican Ozonetherapy Association Congress. AMOZON "For the Integration of Ozonetherapy into the Conventional Medicine” Index Scientific committee ....................................................................................................................................................... 4 Organizing committee .................................................................................................................................................... 4 Sponsors ........................................................................................................................................................................ 5 Preface ..........................................................................................................................................................................
    [Show full text]
  • Abstract Book
    AEPROMO, 2017 Revista Española de Ozonoterapia Vol.7 No. 2. Supplement 1, 2017, ISSN 2174-3215 V International Congress of AEPROMO. VI International Congress of IMEOF “Better Ozone Therapy with Training, Investigation and Publication” Spanish Association of Medical Professionals in Ozone Therapy V International Congress of AEPROMO VI International Congress of IMEOF 1th -3th June, 2017. School of Medicine. Complutense University, Moncloa Campus, Madrid, Spain. Abstract Book Abstract Book 1th - 3th June, 2017. School of Medicine, Complutense University, Madrid, Spain. Organizer: Spanish Association of Medical Professionals in Ozone Therapy (AEPROMO) Page 1 of 96 AEPROMO, 2017 Revista Española de Ozonoterapia Vol.7 No. 2. Supplement 1, 2017, ISSN 2174-3215 V International Congress of AEPROMO. VI International Congress of IMEOF “Better Ozone Therapy with Training, Investigation and Publication” Spanish Association of Medical Professionals in Ozone Therapy Index Scientific Committee ............................................................................................................................................................................. 4 Organizing committee ........................................................................................................................................................................... 4 Sponsors ................................................................................................................................................................................................
    [Show full text]
  • 2020 Declaración-De-Madrid EN-7.Pdf
    MADRID DECLARATION ON OZONE THERAPY (3rd edition) Official document of ISCO3 EDITION No. 01 ISSUE DATE: June 4th, 2010 EDITION No. 02 ISSUE DATE: June 12th, 2015 EDITION No. 03 ISSUE DATE: May 14th, 2020 Copyright (©) 2010, 2015, 2020. ISCO3 (International Scientific Committee of Ozone Therapy) Avenida Juan Andrés 60, local 1 bajo, 28035, Madrid (Spain). All rights reserved. www.isco3.org [email protected] Tel. + 34 91 351 51 75 / +34 669 685 429 ISBN: 978-84-09-19932-7 Statutory Deposit: M-11427-2020 Original language: English. Reviewers: Adriana Schwartz, M.D. Gregorio Martínez Sánchez, Pharm. Dr., Ph.D. Cum Laude. Roberto Quintero, Lawyer Revision of English style: Wayne McCarthy and other members of ISCO3. The only official version of the Madrid Declaration on Ozone Therapy (ISCO3, 3rd edition, 2020) is published in English. Graphic design: Clara Barrachina. Secretarial support: Olga Moreno. Layout and printed by Grafox Imprenta, S.L. (Spain). International Scientific Committee of Ozone Therapy (3rd ed., 2020) “For the Unification of Criteria in the Practice of Ozone Therapy” Official document of ISCO3 1st edition: Approved at the “International Meeting of Ozone Therapy Schools” held at the Royal National Academy of Medicine in Madrid on June 4th, 2010, under the auspices of AEPROMO (Spanish Association of Medical Professionals in Ozone Therapy). 2nd edition with updates and addendum on Dentistry: Approved by ISCO3 on May 10th, 2015 and officially presented at the “International Meeting of the Madrid Declaration on Ozone Therapy (2nd ed.)” held at the Spanish Royal National Academy of Medicine in Madrid on June 12th, 2015, under the auspices of ISCO3 (International Scientific Committee of Ozone Therapy) and the administrative and logistical support of AEPROMO (Spanish Association of Medical Professionals in Ozone Therapy).
    [Show full text]
  • Alberto Alexandre Editor INTRODUCTION
    THE USE OF OZONE IN SPINAL DEGENERATIVE PATHOLOGIES Alberto Alexandre Editor INTRODUCTION Ozone is a very important gas in the stratosphere, reaching its maximum concentration (1000μg/m3above) at a height of 20-30km. Is an unstable gas. It is composed of three atoms of oxygen and has a high breakdown rate ranging in the order of 105-106mol/s. Ozone is 1.6 times denser and 10 times more soluble in water (49.0mLin 100mL of water at 0°C) than oxygen and even though ozone is not a radical molecule, it is the third most powerful oxidant after fluorine and perisulfate. Ozone is produced by three main sources of energy: chemical electrolysis, electrical shock, and UV radiation. Ozone-theraphy has been used for therapeutic purposes since the late XVII century, in different therapeutic modalities with unexpected results in some pathologies. In the scientific literature the first mention of ozone was by the Dutch physicist Van Marumom Mak in 1785. During experiments with a powerful facility for electrification he discovered that in the air around the “ Large lectic Machine” there was a gaseous substance with characteristic smell, which had strong oxidizing properties. In 1840 the professor of the University of Basel Christian Frederick Schonbein related the changes in the properties of oxygen with the formation of a particular gas which he called ozone (from the Greek word ozein “smelly”). Schonbein first detected ozone capacity to merge with biological substrates at positions corresponding to the double bonds. The German chemist Christian Friedrich Schonbein, is also known for the discovery of nitrocellulose.
    [Show full text]
  • Ozone Therapy – a Comprehensive Study of the Literature
    Ozone therapy – A comprehensive study of the literature. M.Nordfors and PA Öckerman. Summary. The gas ozone (O3) was discovered in the 19th century. It consists of three atoms of oxygene. Ozone therapy has been used and studied for more than one hundred years. The effects are proven, consistent, safe and with minimal and preventable side effects. Medical O3 is used to disinfect and to treat diseases. O3 kills bacteria, viruses, fungi, yeast and protozoa, stimulates oxygene metabolism and blood circulation, activates antioxidant mechanisms and the immune system. Ozone is toxic to lung epithelium and the eyes, due to low activity of antioxidants in these tissues. Therefore, it is mainly given as an intravenous infusion, either directly into the blood, as an ozonized saline solution. It can also be given as so-called major autohemotherapy, taking out 50-200 mL blood from the body, which will be ozonized extracorporeally, then infused back again. This can be done from one to 30 times in a row, depending on the treatment tradition and treatment goals. However, most therapists do it only once. There is also a version called EBOO, where you ozonize 3-5 Liters of blood continuosly extracorporeally. Yet another method is to take out a small amount of blood (5-10 mL) , which is ozonized, and then inject it intramuscularly. This is called minor autohemotherapy. A rectal application is easy to perform, has good clinical effects, and can also be performed by the patients themselves in their home. The gas can be injected intramuscularly in a case of muscle damage or muscle pain, paravertebrally when treating back pain, in joints and directly into disc herniation under X-ray supervision as a safe and inexpensive alternative to surgery.
    [Show full text]
  • Advances in Minimally Invasive Surgery and Therapy for Spine and Nerves
    Acta Neurochirurgica Supplements Editor: H.-J. Steiger Advances in Minimally Invasive Surgery and Therapy for Spine and Nerves Edited by Alberto Alexandre Marcos Masini Pier Maria Menchetti Acta Neurochirurgica Supplement 108 SpringerWienNewYork Alberto Alexandre European Neurosurgical Institute, Centro per lo studio e la cura delle malattie del sistema nervoso periferico 31000 Treviso, Italy Marcos Masini School of Medicine, University of Planalto Central and South Lake Hospital, SCN Qd 05 Bl. A Sala 912, Brasilia, Distrito Federal, Brazil Pier Maria Menchetti Florence University, Via Jacopo Nardi, 15, 50132 Firenze, Italy This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically those of translation, reprinting, re use of illustrations, broadcasting, reproduction by photocopying machines or similar means, and storage in data banks. Product Liability: The publisher can give no guarantee for all the information contained in this book. This does also refer to information about drug dosage and application thereof. In every individual case the respective user must check its accuracy by consulting other pharmaceutical literature. The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. # 2011 Springer-Verlag/Wien Printed in Germany SpringerWienNewYork is part of Springer Science+Business Media springer.at Typesetting: SPI, Pondichery, India Printed on acid free and chlorine free bleached paper SPIN: 12674503 With 172 (partly coloured) Figures ISSN 0065 1419 ISBN 978 3 211 99369 9 e ISBN 978 3 211 99370 5 DOI: 10.1007/978 3 211 99370 5 SpringerWienNewYork Preface On behalf of the International Study Group on Spinal Degenerative Pathologies (ISSDP) (head Dr Alberto Alexandre) and the Committee for Peripheral Nerve Surgery of the World Federation of Neurosurgical Societies (head Dr Eduardo Fernandez) and sponsored by EU.
    [Show full text]
  • The Usefulness of Ozone Treatment in Spinal Pain Open Access to Scientific and Medical Research DOI
    Journal name: Drug Design, Development and Therapy Article Designation: Review Year: 2015 Volume: 9 Drug Design, Development and Therapy Dovepress Running head verso: Bocci et al Running head recto: The usefulness of ozone treatment in spinal pain open access to scientific and medical research DOI: http://dx.doi.org/10.2147/DDDT.S74518 Open Access Full Text Article REVIEW The usefulness of ozone treatment in spinal pain Velio Bocci1 Objective: The aim of this review is to elucidate the biochemical, molecular, immunologi- Emma Borrelli2 cal, and pharmaceutical mechanisms of action of ozone dissolved in biological fluids. Studies Iacopo Zanardi1 performed during the last two decades allow the drawing of a comprehensive framework for Valter Travagli1 understanding and recommending the integration of ozone therapy for spinal pain. Methods: An in-depth screening of primary sources of information online – via SciFinder 1Department of Biotechnology, Chemistry and Pharmacy, Università Scholar, Google Scholar, and Scopus databases as well as Embase, PubMed, and the Cochrane degli Studi di Siena, 2Department of Database of Systemic Reviews – was performed. In this review, the most significant papers Medical Biotechnologies, University of of the last 25 years are presented and their proposals critically evaluated, regardless of the Siena, Siena, Italy bibliometric impact of the journals. Results: The efficacy of standard treatments combined with the unique capacity of ozone therapy to reactivate the innate antioxidant system is the key to correcting the oxidative stress typical of chronic inflammatory diseases. Pain pathways and control systems of algesic signals after ozone administration are described. Conclusion: This paper finds favors the full insertion of ozone therapy into pharmaceutical sciences, rather than as either an alternative or an esoteric approach.
    [Show full text]
  • Ijot 10 1 Id76
    The Official Journal of INTERNATIONAL JOURNAL OF WFOOT - World Federation of Oxygen-Ozone Therapy, FIO - Italian Federation of Ozone Therapy, OZONE THERAPY ACEOOT - Spanish Association of Ozone Therapy, formerly RIVISTA ITALIANA DI OSSIGENO-OZONOTERAPIA Hellenic, Indian, Slovach and Chinese National Societies VOLUME 10 - No. 1 - APRIL 2011 CENTAURO S.r.l., BOLOGNA ISSN 1972-3539 INTERNATIONAL JOURNAL OF OZONE THERAPY formerly RIVISTA ITALIANA DI OSSIGENO-OZONOTERAPIA ThE OffICIAL JOURNAL Of WfOT - WORLD fEDERATION Of OxyGEN-OZONE ThERAPy, fIO - ITALIAN fEDERATION Of OZONE ThERAPy, ACEOOT - SPANISh ASSOCIATION Of OZONE ThERAPy, hELLENIC, INDIAN, SLOVACh AND ChINESE NATIONAL SOCIETIES Index edItorIal Part II - Oral Communications 37 Prof. M. Bonetti 5 session II - Randomized Clinical Studies 41 Prof. M. leonardi 7 session III - World Experiences 43 Saturday April 16th III World Congress of Oxygen-Ozone Therapy V° Congresso Nazionale F.I.O. session IV - Other Applications 45 From 14th To 16 th April 2011- Brescia Italy session IV - Oral Communications 51 session IV - Satellite Symposia 57 "Francesco rIccardo MontI" 8 Prize for research into oxygen-ozone therapy Parallel session - Veterinary Medicine 59 ProGraMMe 9 Posters session 63 Thursday April 14th authors Index 70 opening ceremony 21 Information & Congresses 22, 28, 36, 40, 44, 62 Friday April 15th WFOT Application Form 74 session I - Ozone Therapy in the 23 Muscolo-Skeletal Pathology Subscription Form 75 Part I - Spine FIO Application Form 76 Part I - Oral Communications 29 Part II
    [Show full text]
  • And Ozone Therapy
    Ozone Velio Bocci Ozone A New Medical Drug Second Edition 1 3 Velio Bocci Department of Physiology University of Siena via A. Moro 2 53100 Siena Italy [email protected] ISBN 978-90-481-9233-5 e-ISBN 978-90-481-9234-2 DOI 10.1007/978-90-481-9234-2 Springer Dordrecht Heidelberg London New York Library of Congress Control Number: 2010936097 © Springer Science+Business Media B.V. 2005, 2011 No part of this work may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording or otherwise, without written permission from the Publisher, with the exception of any material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) This book is dedicated to all patients with the wish to regain their health with or without oxygen-ozonetherapy Foreword In 2002, Prof. Bocci published a book entitled “Oxygen-Ozone Therapy. A Critical Evaluation” with ample scientific data based largely on his experiments indicat- ing the usefulness and atoxicity of ozone therapy in some diseases. However the book contained too many details and it was difficult to read for the busy physi- cian and even more for the layman. He has now written a new version that is shorter and concise. Nonetheless the mechanisms of action of ozone, which are essential for understanding how ozone acts through a number of messengers, are clearly explained in a scientific but plain language.
    [Show full text]
  • MADRID DECLARATION on OZONE THERAPY 2 EDITION Official
    Original language: English MADRID DECLARATION ON OZONE THERAPY 2nd EDITION Official document of ISCO3 1st. Edition: Approved at the "International Meeting of Ozone Therapy Schools" held at the Royal Academy of Medicine in Madrid on June 4th, 2010, under the auspices of AEPROMO (Spanish Association of Medical Professionals in Ozone Therapy). 2nd. Edition: Approved by ISCO3 at the “International Meeting of the Madrid Declaration on Ozone Therapy” held at the Royal Academy of Medicine in Madrid on June 12th, 2015, under the auspices of ISCO3 (International Scientific Committee of Ozone Therapy) and the administrative and logistical support of AEPROMO (Spanish Association of Medical Professionals in Ozone Therapy). EDITION: Edition No. 01 ISSUE DATE: June 4 th , 2010 EDITION: Edition No. 02 ISSUE DATE: June 12 th , 2015 Taking into account since the discovery of the ozone by the German chemist Christian Friedrich Schönbein in 1840, its medical use has increased in different parts of the world and there is more interest from health professionals to know how it works and its benefits. Accordingly, the number of ozone-therapist keeps growing all over the world with an increasing number of patients benefiting from it. Although great efforts and advances have been made since the approval of the 1st edition of the Declaration in 2010, the consolidation of ozone therapy has not been easy, resistance is still found within the medical community and its recognition in the legal field will require more coordinated efforts. Recalling that pre-clinical research and clinical trials on the use of ozone therapy have been carried out in Cuba, Germany, Italy, Russia, Spain and other countries, with considerable scientific rigor, obtaining results that support its practice using different medical protocols.
    [Show full text]